Bell David, Jedynak Justin, Bell Roger
Department of Vascular Surgery, Monash Medical Centre, Clayton, Victoria, Australia.
ANZ J Surg. 2014 Jan-Feb;84(1-2):68-72. doi: 10.1111/ans.12098. Epub 2013 Feb 21.
Endoscopic thoracic sympathectomy (ETS) provides definitive management for primary focal hyperhidrosis and facial blushing. These conditions are debilitating and not uncommon, but many clinicians avoid ETS due to the risk of complications, particularly compensatory sweating (CS). This retrospective cohort study aimed to evaluate the degree of symptom resolution, patient satisfaction and adverse reactions after ETS and to identify subgroups of patients more likely to achieve a satisfactory outcome.
From 2004 to 2010, 210 patients underwent ETS performed by a single surgeon. These patients responded to a questionnaire regarding levels of satisfaction, symptom resolution and complications encountered, particularly CS.
Palmar hyperhidrosis (97%) and scalp/facial hyperhidrosis (93%) demonstrated greater degrees of symptom resolution than axillary hyperhidrosis (71%) and facial blushing (71%) (P < 0.001). Rates of severe CS were lowest in patients with palmar hyperhidrosis (8%) and highest in patients with axillary (26%) and scalp/facial (44.5%) hyperhidrosis (P = 0.0003). The probability of experiencing no CS was highest at young ages and decreased with age (P = 0.0006). Satisfaction rates also fell as age increased (P = 0.004). Satisfaction rates were highest in patients with palmar (90%) and lowest in patients with scalp/facial (52%) hyperhidrosis (P < 0.02).
Patient satisfaction following ETS is highest among younger patients and those undergoing the procedure for palmar hyperhidrosis. Dissatisfaction arises from failure to achieve the desired aim as well as the development of severe CS, which is more common in older patients and those undergoing ETS for axillary and scalp/facial hyperhidrosis.
内镜胸交感神经切除术(ETS)为原发性局灶性多汗症和面部潮红提供了确定性治疗。这些病症令人衰弱且并不罕见,但许多临床医生因并发症风险,尤其是代偿性出汗(CS)而避免实施ETS。这项回顾性队列研究旨在评估ETS后症状缓解程度、患者满意度和不良反应,并确定更有可能获得满意结果的患者亚组。
2004年至2010年,210例患者接受了由同一位外科医生实施的ETS。这些患者对一份关于满意度、症状缓解情况和所遇到并发症(尤其是CS)的问卷做出了回应。
手掌多汗症(97%)和头皮/面部多汗症(93%)的症状缓解程度高于腋窝多汗症(71%)和面部潮红(71%)(P < 0.001)。手掌多汗症患者中严重CS的发生率最低(8%),腋窝(26%)和头皮/面部(44.5%)多汗症患者中最高(P = 0.0003)。无CS发生的概率在年轻时最高,并随年龄增长而降低(P = 0.0006)。满意度也随年龄增加而下降(P = 0.004)。手掌多汗症患者的满意度最高(90%),头皮/面部多汗症患者的满意度最低((52%)(P < 0.02)。
ETS后的患者满意度在年轻患者和接受手掌多汗症手术的患者中最高。不满源于未能达到预期目标以及严重CS的发生,这在老年患者以及接受ETS治疗腋窝和头皮/面部多汗症的患者中更为常见。